Health ❯ Medical Research ❯ Neurology

Alzheimer's Disease

Biomarkers Cognitive Impairment Cognitive Decline Detection Methods Diagnosis Diagnostic Tests Gene Expression Dopamine and Neprilysin Interaction Hypertension IDO1 Inhibitors Phases of Alzheimer's Xenon Treatment Neurovascular Unit Clinical Trials Brain Samples Proteomics Protein Research Amyloid Beta Plaques Artificial Intelligence in Medicine Lithium Deficiency Lithium Lithium and Alzheimer's Treatment Methods Nonpharmaceutical Treatments Lipidomics Lithium Treatment Omega Fatty Acids Diagnostic Tools Brain Simulation Early Detection Techniques Blood Tests Tau Pathology Obesity Impact Blood-Brain Barrier Treatment Strategies Treatment Innovations Kidney Function Nanotechnology Lipid Metabolism Amyloid Proteins Risk Prediction Models Charity Charity Fundraising Funding Charity Events Predictive Testing Predictive Models Retinal Changes Estrogen and Alzheimer's Prevention Strategies Dopamine Tau Proteins GRK2 Enzyme Research Risk Assessment Brain Immune Cells APOE4 Gene Effects Innovative Technologies

APOE4 Reprograms Brain Vessel Cells and Impairs Astrocyte Waste Clearance

This preclinical research identifies TGF-β and astrocyte cholesterol-lysosome pathways as drug targets to restore vessel health.

Blood Test p‑tau217 Predicts Alzheimer Risk but Not Ready for Routine Screening

ETH Zurich Pins GRK2 Aggregation as Alzheimer’s Target and Reveals 'Compound 10' That Slows Decline in Mice

Brain Estrogen Loss Alters Hippocampal Matrix and Impairs Memory in Older Female Mice

Blood Studies Point to Complementary Alzheimer’s Biomarkers for Prediction and Staging

Noninvasive Brain Blood-Flow Markers Align With Alzheimer’s Imaging Signs

p‑Tau217 Blood Tests Boost Alzheimer’s Diagnosis and Predict Onset Within a Few Years

Blood ‘Clock’ Predicts Alzheimer’s Symptom Onset Within 3–4 Years

Finger-Prick Blood Spot Test Detects Alzheimer’s Biomarkers With 86% Accuracy

Blood Markers Tie Obesity to Faster Alzheimer’s Progression

Engineered Nanoparticles Restore Blood–Brain Barrier and Clear Amyloid in Alzheimer’s Mice

Nanoparticles Restore Brain Barrier, Reverse Alzheimer’s Signs in Mice

Study Finds Blood-Brain Barrier Largely Intact in Key Alzheimer’s Mouse Model

UK Launches NHS Trial of £100 Blood Test to Speed Alzheimer’s Diagnosis

Study Ties Lower Omega-3–Linked Blood Lipids to Alzheimer’s in Women

Researchers Identify Lithium Deficiency as Alzheimer’s Cause and Reverse Pathology in Mice

Dietary Compounds Restore Energy and Protein Clearance in Aging Neurons

Newborns’ Blood p-Tau217 Levels Surpass Those in Alzheimer’s Patients

Insulin Resistance Blood Test Forecasts Rapid Alzheimer’s Decline